SY
Putnam BioRevolution ETF
SYNB · AMEX
$31.61 -0.37% (-$0.12)
Market Cap ¥37.4M
P/E Ratio -159.26x
Div. Yield 0.68%
ROE -
Valuation
65 /100
Fair P/E -159.26x
P/B 0.01x
P/S 0.02x
Growth
55 /100
Stable EPS growth 9.23%
Book val. growth 4.57%
Rev. growth 17.83%
Profitability
0 /100
Weak Net margin 90.07%
Op. margin 119.05%
Gross margin N/A
Quality
30 /100
Poor ROA 15.38%
Asset turnover 0.17x
ROIC N/A
Debt
100 /100
Low Current ratio 1.23x
Debt/Equity N/A
Debt/Assets N/A
Stability
70 /100
Stable Beta 1.07x
Profitable years 6
Rev. volatility 69.90%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o SYNB
Online
Sector
Financial Services
Industry
Asset Management
CEO
-
Employees
-
Headquarters
San Mateo